Bullet Blockchain, Inc.
BULT News Today: Stay Updated with the Latest Bullet Blockchain, Inc. News in Real Time
Find BULT news now at Meyka AI. Stay informed with the latest Bullet Blockchain, Inc. stocks updates, including price news, market analysis, and expert insights.

CVLG Officer Sells 22,388 Shares at $30.75 on April 20, 2026
Covenant Logistics CFO Grant James S III sold 22,388 CVLG shares at $30.75 on April 20, 2026. Total value: $688,431.

RMD.AX ResMed Inc. Earnings Recap April 2026
ResMed Inc. (RMD.AX) reported earnings on April 21, 2026. Stock down 3.27% with market cap at $45.95B. Meyka AI rates B+.

3681.T Stock Plunges 15.6% in After-Hours Trading on JPX
V-cube Inc. (3681.T) drops 15.6% to ¥54 in after-hours JPX trading. Stock hits 52-week lows amid profitability challenges.

OABI Directors Sell $168M Stock: Gotwals, Crouse Dispose RSUs April 22
OmniAb directors Gotwals and Crouse each sold 13,333 RSUs on April 21, 2026. Two simultaneous insider dispositions signal potential liquidity moves.

SI Stock: COO Matthew Fraser Acquires 14,243 Shares April 22, 2026
Shoulder Innovations COO Matthew Fraser acquired 14,243 SI shares at $2.86 on April 20. Insider buying signal for the $284M market cap company.

VIK.CN Stock Surges 50% on Rights Offering Announcement
VIK.CN stock jumps 50% to C$0.015 on Avila Energy’s rights offering. Oil & gas explorer shows strong trading volume on CNQ exchange.

Ethereum (ETHUSD) and Solana’s Quantum Defense Strategy Compared to Bitcoin
In March 2026, researchers and major tech firms warned that quantum computers could break today’s cryptography much sooner than expected, possibly within the next decade. This is a serious concern for crypto markets. Networks like Bitcoin, Ethereum, and Solana all rely on encryption that may not survive a quantum attack. That means digital assets worth…

KLRA Insider Buying: Bain Capital Acquires 9.96M Shares April 22, 2026
Bain Capital entities acquire 9.96M KLRA shares for $159.4M on April 20, 2026. Major insider buying signal for Kailera Therapeutics.

SU Maintained at Sector Perform by Scotiabank April 2026
Scotiabank maintains SU at Sector Perform, raises price target to C$90 from C$85. Stock trades at $62.55.